KA
Insider
Kamran Alam
CHIEF FINANCIAL OFFICERKamran Alam (CHIEF FINANCIAL OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Taysha Gene Therapies, Inc. (TSHA). The largest single filing was $485K of TSHA (102,817 sh across 2 lots, as filed), executed Jan 23.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$485K
shares × price, as filed
Last traded
Jan 26
Filed Jan 27
Median ADV $19.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $640K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
TSHARecent filings
TSHASALE
Taysha Gene Therapies, Inc.
View filing →
$485K102,817 sh across 2 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET TSHASALE Taysha Gene Therapies, Inc. View filing → $155K
54,491 sh × $2.85
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET